Efficacy and safety of PEG-rhG-CSF for preventing neutropenia after chemotherapy with doxorubicin plus carboplatin in epithelial ovarian cancer patients:A retrospective clinical study

LIU Lin; LI Runrong; GONG Shipeng

doi:10.3969/j.issn.1006-5725.2023.17.015

Home>Articles>Efficacy and safety of PEG-rhG-CSF for preventing neutropenia after chemotherapy with doxorubicin plus carboplatin in epithelial ovarian cancer patients:A retrospective clinical study

DOI: 10.3969/j.issn.1006-5725.2023.17.015

Efficacy and safety of PEG-rhG-CSF for preventing neutropenia after chemotherapy with doxorubicin plus carboplatin in epithelial ovarian cancer patients:A retrospective clinical study

LIU Lin

LI Runrong

GONG Shipeng

Keywords：ovarian cancerchemotherapydoxorubicinneutropeniahuman granulocyte stimu-lating factor

Publication Date：2023-09-10

Online Publishing Date：2025-08-15(First online date of this platform, not the publication date of the document)

Pages：5( 2236-2240 )

The Journal of Practical Medicine

ISTICPKU

ISSN：1006-5725

Year, Vol.(Issue)：2023,39(17)